Everything We’re Saying, and Everything Being Said About Us
Explore the stories behind our science and the people it serves.
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and new research on inclusive oncology AI.
PAICON at the German Indian Innovation Corridor
At the German Indian Innovation Corridor in Berlin, PAICON joined thought leaders shaping the future of global innovation. Our CEO...
A Test Too Late: When Standard Chemo Becomes Deadly
Each year, over a thousand patients die from preventable chemotherapy toxicity caused by genetic variants like DPYD deficiency. This story...
Technical vs. Biological Diversity: Designing for Generalization
AI in pathology can achieve high accuracy in controlled environments but often struggles to generalize across scanners, stains, and patient...
PAICON at the European Congress of Pathology 2025 in Vienna
PAICON was proud to be part of the 37th European Congress of Pathology in Vienna, where leading experts gathered to...
PAICON at HGS MathComp Annual Retreat 2025
PAICON was honored to participate in the HGS MathComp Annual Retreat 2025, an event that brought together fellows, alumni, and...
From Germany to the UK: PAICON at Cambridge Tech Week
We joined the Cambridge Tech Week 2025, where innovation meets community and ideas move seamlessly between research, industry, and entrepreneurship....
PAICON at the MSI Symposium Heidelberg 2025
Dr. Witali Aswolinskiy, AI Lead at PAICON, delivered a talk at the European Symposium on Tumors with Microsatellite Instability (MSI)...
PAICON at WHX Tech 2025: Driving Equity in Cancer Diagnostics
We exhibited at WHX Tech 2025, presenting our vision of transforming cancer care with genetically and technically diverse data combined...
Equity in Clinical Trials: Closing the Participation Gap
Clinical trials are the foundation of progress in cancer care. Yet participation in clinical trials remains unequal.
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and
new research on
inclusive oncology AI.